glp 1 dementia prevention GLP-1 and Alzheimer's Disease: Research on Neuroprotective Potential Could diabetes and weight loss

Mounjaro works by activating both GLP-1 and GIP receptors, slowing digestion, reducing appetite, and improving blood sugar regulation, mechanisms that together support meaningful, evidence-based weight loss

J.NofalM.CommissoC.HackettS

Monitoring Parameters When Co-Prescribing Clinical Signs to Track Patients co-using GHK-Cu and pregabalin should be evaluated at each visit for: Excess somnolence or sedation beyond what pregabalin alone produces at baseline Dizziness, ataxia, or balance disturbance Cognitive slowing or memory complaints new to the combination period Skin or injection-site reactions (specific to subcutaneous GHK-Cu) Pregabalin does not have a standard therapeutic drug monitoring serum assay used in outpatient practice, so monitoring is clinical rather than laboratory-based for most patients [4]

Recovery Downtime is minimal

This quest for optimal health often leads to a desire to integrate different approaches, sparking questions about how they might work together